Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CARISMA-THERAPEUTICS-INC-43427965/news/Carisma-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1-Study-of-CT-0508-in-Combination-with-K-44230288/?utm_source=whatsapp&utm_medium=social&utm_campaign=share